Press Releases

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

Oslo, Norway – 16 May 2024 - IDEX Biometrics will give a webcast presentation today at 09:00 CET in connection with its interim report for the first quarter of 2024. The presentation will be held by Vince Graziani, Chief Executive Officer, and Catharina Ekløf, Chief Commercial and Operating Officer. The webcast presentation can be viewed at the following link:

https://idexbiometrics.videosync.fi/q1-2024

The presentation file is also available on the IDEX... (continue reading...)

STOCKHOLM, May 16, 2024 /PRNewswire/ -- Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.

A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.

The presentation... (continue reading...)

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

Bioretec Ltd  Company announcement 16 May 2024 at 8:30 a.m.

TAMPERE, Finland, May 16, 2024 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March 2024. The complete business review is attached to this release as a PDF file and available on the company's website at https://bioretec.com/investors/investors-in-english/releases.

January-March 2024 in brief

• Net sales amounted to EUR 682 thousand (1-3/2023: EUR 1,071 thousand).
• The... (continue reading...)